Type 2 Diabetes
Conditions
Brief summary
To study the effects of crocin supplement in patients with type 2 diabetes, 50 patients will be randomly allocated to placebo group and 2 tablets of crocin for 12 weeks. At the first and the end of the intervention, lipid profiles, blood pressure, blood sugar, inflammatory and anthropometric factors will be assessed and compared between groups.
Interventions
DIETARY_SUPPLEMENTcrocin
2 tablets crocin per day
DIETARY_SUPPLEMENTplacebo
2 tablets placebo per day
Sponsors
Vahideh Behrouz
Ali Dastkhosh
National Nutrition and Food Technology Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
Age of 40 to 65 years type 2 diabetes: and body mass index range of 18.5 to 30 kg/m2
Exclusion criteria
pregnancy or lactation A history of Cardiovascular disease, Pulmonary disease, Renal disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| type 2 diabetes | 12 weeks | number of participants with normal plasma glucose |
Countries
Iran
Outcome results
None listed